• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清钙化倾向与外周动脉疾病的心血管结局。

Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.

机构信息

Division of Nephrology, Medicine III, Medical University of Vienna, Austria.

Department of Medicine III, Nephrology, Transplantation Medicine, Rheumatology, Geriatrics, Ordensklinikum Linz Elisabethinen, Linz, Austria.

出版信息

Thromb Haemost. 2022 Jun;122(6):1040-1046. doi: 10.1055/s-0041-1736444. Epub 2021 Oct 31.

DOI:10.1055/s-0041-1736444
PMID:34719013
Abstract

Peripheral artery disease (PAD) has been shown to be linked to elevated cardiovascular risk. The novel T test quantifies calcification propensity of serum and has been associated with cardiovascular events and mortality in patients with chronic kidney disease (CKD) and in the general population. This study investigated the association of calcification propensity measured by the T test in 287 patients with PAD without severe CKD. Major cardiovascular events (MACEs) including nonfatal stroke and nonfatal myocardial infarction and all-cause death (MACE + ) were evaluated after a median follow-up of 4 years and long-term cardiovascular and all-cause mortality after a median follow-up of 8.7 years by Kaplan-Meier and Cox regression analyses. Mean T time was 268 ± 63 minutes in the study cohort (age 69 ± 10 years, 32% women, 47% diabetes). Low T values that signify high calcification propensity were significantly associated with the occurrence of MACE+ (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.55-0.94). This association sustained multivariate adjustment for cardiovascular risk factors (CVRFs), Fontaine PAD stage, and prevalent media sclerosis (HR: 0.65; CI: 0.47-0.91). Cardiovascular mortality was significantly associated with T after multivariate adjustment for CVRF (HR: 0.72; CI 0.53-0.99), but not all-cause mortality (HR: 0.80; CI: 0.64-1.01). In conclusion, calcification propensity associates with MACE+ and cardiovascular mortality in patients with PAD.

摘要

外周动脉疾病 (PAD) 与心血管风险升高有关。新型 T 检验定量检测血清钙化倾向,与慢性肾脏病 (CKD) 患者和普通人群中的心血管事件和死亡率相关。本研究调查了 287 例无严重 CKD 的 PAD 患者 T 检验测量的钙化倾向与主要心血管事件 (MACE) 的相关性,MACE 包括非致死性中风和非致死性心肌梗死以及全因死亡 (MACE + )。中位随访 4 年后,通过 Kaplan-Meier 和 Cox 回归分析评估 MACE + 的发生,中位随访 8.7 年后评估长期心血管和全因死亡率。研究队列的平均 T 时间为 268 ± 63 分钟(年龄 69 ± 10 岁,32%为女性,47%患有糖尿病)。表示高钙化倾向的低 T 值与 MACE + 的发生显著相关(风险比[HR]:0.72;95%置信区间[CI]:0.55-0.94)。这种关联在多变量调整心血管危险因素 (CVRF)、Fontaine PAD 分期和普遍存在的媒体硬化后仍然存在(HR:0.65;CI:0.47-0.91)。多变量调整 CVRF 后,心血管死亡率与 T 显著相关(HR:0.72;CI 0.53-0.99),但与全因死亡率无关(HR:0.80;CI:0.64-1.01)。总之,钙化倾向与 PAD 患者的 MACE + 和心血管死亡率相关。

相似文献

1
Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.血清钙化倾向与外周动脉疾病的心血管结局。
Thromb Haemost. 2022 Jun;122(6):1040-1046. doi: 10.1055/s-0041-1736444. Epub 2021 Oct 31.
2
Serum Calcification Propensity and Clinical Events in CKD.血清钙化倾向与 CKD 的临床事件。
Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1562-1571. doi: 10.2215/CJN.04710419. Epub 2019 Oct 28.
3
Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population: The PREVEND Study.人群中血清钙化倾向与心血管和全因死亡率的关系:PREVEND 研究。
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1942-1951. doi: 10.1161/ATVBAHA.120.314187. Epub 2020 Jun 4.
4
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.血清钙化倾向与慢性肾脏病患者的冠状动脉钙化:CRIC(慢性肾功能不全队列)研究。
Am J Kidney Dis. 2019 Jun;73(6):806-814. doi: 10.1053/j.ajkd.2019.01.024. Epub 2019 Mar 29.
5
Serum calcification propensity predicts all-cause mortality in predialysis CKD.血清钙化倾向可预测透析前 CKD 的全因死亡率。
J Am Soc Nephrol. 2014 Feb;25(2):339-48. doi: 10.1681/ASN.2013060635. Epub 2013 Oct 31.
6
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.在 EVOLVE 试验中接受血液透析的患者的血液钙化倾向、心血管事件和生存。
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):315-322. doi: 10.2215/CJN.04720416. Epub 2016 Dec 9.
7
Serum Calcification Propensity Is Increased in Myocardial Infarction and Hints at a Pathophysiological Role Independent of Classical Cardiovascular Risk Factors.血清钙化倾向在心肌梗死中增加,并提示其独立于经典心血管危险因素的病理生理作用。
Arterioscler Thromb Vasc Biol. 2024 Aug;44(8):1884-1894. doi: 10.1161/ATVBAHA.124.320974. Epub 2024 Jun 20.
8
The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.增加透析液镁对终末期肾病患者血清钙化倾向的影响:一项随机对照临床试验。
Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1373-1380. doi: 10.2215/CJN.13921217. Epub 2018 Aug 21.
9
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.血清钙磷复合物颗粒大小和转化时间与新发生血液透析患者动脉钙化、动脉僵硬度和死亡率的相关性。
Am J Kidney Dis. 2021 Mar;77(3):346-354. doi: 10.1053/j.ajkd.2020.05.031. Epub 2020 Aug 13.
10
Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease.痛风与外周动脉疾病患者主要不良心血管事件和全因死亡率的关系。
Atherosclerosis. 2020 Nov;312:23-27. doi: 10.1016/j.atherosclerosis.2020.08.029. Epub 2020 Sep 8.

引用本文的文献

1
Effect of dialysate bicarbonate on calciprotein particle crystallization time (T50) in hemodialysis patients-the D-Bic study.透析液碳酸氢盐对血液透析患者钙蛋白颗粒结晶时间(T50)的影响——D-Bic研究
Clin Kidney J. 2025 Aug 13;18(9):sfaf263. doi: 10.1093/ckj/sfaf263. eCollection 2025 Sep.
2
Association between cardiovascular disease and peripheral arterial disease implications for patient safety.心血管疾病与外周动脉疾病之间的关联对患者安全的影响
BMC Cardiovasc Disord. 2025 Aug 7;25(1):586. doi: 10.1186/s12872-025-05054-3.
3
Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients - The CitMag Study.
柠檬酸缓冲、富镁透析液对血液透析患者钙化倾向的影响——CitMag研究
Kidney Int Rep. 2024 Mar 25;9(6):1765-1773. doi: 10.1016/j.ekir.2024.03.023. eCollection 2024 Jun.
4
Ectopic Calcification: What Do We Know and What Is the Way Forward?异位钙化:我们了解什么以及未来的方向是什么?
J Clin Med. 2023 May 26;12(11):3687. doi: 10.3390/jcm12113687.
5
Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study.与阿法骨化醇治疗相比,依特卡肽治疗对骨特异性碱性磷酸酶和血清钙化倾向无影响,且仅骨特异性碱性磷酸酶与成纤维细胞生长因子23相关:ETACAR-HD研究的亚分析结果
Front Med (Lausanne). 2022 Jul 6;9:948177. doi: 10.3389/fmed.2022.948177. eCollection 2022.